Community-based eye disease screening to prevent blindness

Village-Integrated Eye Worker Trial II (VIEW II) Extension

['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10934924

This study is looking at how community eye screenings can help catch eye problems early, like glaucoma and age-related macular degeneration, in people living in Nepal, so they can get the care they need before it leads to blindness.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded)
Locations1 site (SAN FRANCISCO, UNITED STATES)
Trial IDNIH-10934924 on ClinicalTrials.gov

What this research studies

This research focuses on preventing avoidable blindness in resource-limited settings by implementing community-based eye disease screening. It involves visual acuity assessments and advanced diagnostic techniques like optical coherence tomography (OCT) and intraocular pressure (IOP) measurements. Communities in Nepal are randomly assigned to receive either the screening intervention or no intervention, allowing researchers to evaluate the effectiveness of early detection and referral for conditions such as glaucoma and age-related macular degeneration. The project aims to identify cases before they lead to irreversible vision loss and improve overall community eye health.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living in resource-limited settings who are at risk for progressive eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration.

Not a fit: Patients who do not reside in the targeted communities or who do not have risk factors for the eye diseases being screened may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of blindness caused by progressive eye diseases in underserved communities.

How similar studies have performed: Previous research has shown that community-based screening approaches can effectively reduce the prevalence of blindness in similar populations, indicating a promising avenue for this intervention.

Where this research is happening

SAN FRANCISCO, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.